Following the launch of our new RayOne EMV intraocular lens, Plus1 EMV shines a light on the changing landscape of presbyopia correction in cataract and refractive surgery. With a global calendar of webinars, interviews, articles, social media and in-person events, join the conversation with leading surgeons from around the world.
Watch interviews with surgeons about their experience with RayOne EMV, and gain pearls of wisdom for achieving the best visual outcomes for your presbyopic patients.
Catch up on previous webinars to gain a greater insight on the benefits of RayOne EMV for your patients.
Watch or relive some of our Plus1 EMV live events from around the world where surgeons have come together to learn and discuss the opportunity created by RayOne EMV for their patients.
Download RayOne EMV resources focused on clinical outcomes, patient suitability and clinic positioning.
RayOne EMV was developed in collaboration with Professor Graham Barrett and uniquely extends a patient’s range of vision with a patented non-diffractive optic profile, enabling the depth of field of many presbyopia-correcting IOLs but with reduced dysphotopsia, short neuroadaptation, reliable outcomes, high patient satisfaction, and improved affordability. To learn more about RayOne EMV, click here.
If you have any questions about Plus1 EMV or would like to arrange a trial of RayOne EMV, please speak to your local Rayner representative or contact marketingteam@rayner.com.
To continue the conversation about RayOne EMV, our new non-diffractive extended vision lens, please complete the enquiry form below.
May 6, 2021
Join upcoming Plus1 EMV events intended to extoll the benefits of RayOne EMV.
PRECAUTION: The safety and effectiveness of the RayOne EMV (RAO200E) has not been substantiated in clinical trials. The effects of the RayOne EMV IOL optical design on quality of vision, contrast sensitivity, and subjective visual disturbances (glare, halo, etc.) have not been evaluated clinically. Certain lab-based testing of the RayOne EMV IOL may aid surgeons in understanding the theoretical image quality expected with the RayOne EMV IOL compared to other Rayner FDA approved lenses, but such testing does not fully assess all aspects of clinical difficulties under all conditions. You must discuss with your surgeon the potential benefits of the modified optical design of the RayOne EMV IOL against the potential for risks associated with a degradation in vision quality and the lack of clinical data to characterize the impact of the RayOne EMV IOL optical design on contrast sensitivity and subjective visual disturbance. These considerations may be especially relevant to patients with certain preexisting ocular conditions (prior eye surgery, irregular corneal astigmatism, severe corneal dystrophy, macular disease, optic nerve atrophy, etc).
CAUTION: United States Federal Law restricts this device to sale and distribution by or on the order of a physician and its use is restricted to a properly licensed physician.
Rayner cannot offer medical advice to members of the public. For such advice you should consult a medical professional. Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.
